Located in Grenoble and Lyon France, PX’Therapeutics provides integrated biotherapeutics and recombinant vaccines development and manufacturing contract services. Organized around three integrated service platforms (recombinant protein R&D, monoclonal antibody development, cGMP manufacturing), PX’Therapeutics offers custom programmes which may include murine antibody generation, humanization strategies, protein engineering, process development and small scale cGMP manufacturing services.